Adalimumab-Adaz
1 NDC across 1 manufacturer|1 Generic,0 Brand
Adalimumab-Adaz is used to treat juvenile arthritis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, crohn disease and hidradenitis suppurativa, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
In 2024, Medicare Part D spent $15 million on Adalimumab-Adaz across 4,540 claims for 1,411 beneficiaries.
Adalimumab-Adaz is available as 1 NDC from 1 manufacturer (1 generic, 0 brand), with NADAC prices from $1587.82 to $1587.82 per ML. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
1G / 0B
Manufacturers
1
competing in market
Price Spread
$1587.82 – $1587.82
per ML
7d Activity
avg +0.1% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Sandoz Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Tumor Necrosis Factor Blocker class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing ADALIMUMAB-ADAZ
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ADALIMUMAB-ADAZ(CF) PEN 40 MG/0.4 ML | $1587.8176 per ML | +0.07% |
Frequently Asked Questions
What is Adalimumab-Adaz used to treat?
Adalimumab-Adaz is used to treat juvenile arthritis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, crohn disease and hidradenitis suppurativa, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Adalimumab-Adaz?
In 2024, Medicare Part D spent $15 million on Adalimumab-Adaz across 4,540 claims for 1,411 beneficiaries.
How many Adalimumab-Adaz products are on the market?
The Adalimumab-Adaz drug market contains 1 NDC from 1 manufacturer — 1 generic and 0 brand products.
What is the price range for Adalimumab-Adaz?
NADAC reference prices for Adalimumab-Adaz range from $1587.8176 to $1587.8176 per ML.
Which manufacturers make Adalimumab-Adaz?
1 manufacturer lists Adalimumab-Adaz in NADAC. Ranked by number of NDCs, the largest are Sandoz Inc. (1).
How has the price of Adalimumab-Adaz changed recently?
Over the past 7 days, 1 Adalimumab-Adaz NDC rose and 0 fell, with a market-wide average change of +0.1%.